Cardinal Health Com (CAH) Shareholder Cullen Frost Bankers Lifted Holding; Immunomedics (IMMU) Stock Value Rose While First Light Asset Management Cut Stake

January 19, 2018 - By Henry Gaston

First Light Asset Management Llc decreased its stake in Immunomedics Inc (IMMU) by 35.98% based on its latest 2017Q3 regulatory filing with the SEC. First Light Asset Management Llc sold 737,129 shares as the company’s stock rose 37.64% with the market. The institutional investor held 1.31 million shares of the health care company at the end of 2017Q3, valued at $18.34M, down from 2.05M at the end of the previous reported quarter. First Light Asset Management Llc who had been investing in Immunomedics Inc for a number of months, seems to be less bullish one the $2.55 billion market cap company. The stock decreased 0.94% or $0.15 during the last trading session, reaching $15.84. About 1.65 million shares traded. Immunomedics, Inc. (NASDAQ:IMMU) has risen 76.26% since January 19, 2017 and is uptrending. It has outperformed by 59.56% the S&P500.

Cullen Frost Bankers Inc increased its stake in Cardinal Health Inc Com (CAH) by 58.79% based on its latest 2017Q3 regulatory filing with the SEC. Cullen Frost Bankers Inc bought 32,387 shares as the company’s stock declined 8.93% while stock markets rallied. The institutional investor held 87,472 shares of the health care company at the end of 2017Q3, valued at $5.85M, up from 55,085 at the end of the previous reported quarter. Cullen Frost Bankers Inc who had been investing in Cardinal Health Inc Com for a number of months, seems to be bullish on the $22.56B market cap company. The stock decreased 1.29% or $0.94 during the last trading session, reaching $71.71. About 3.83 million shares traded or 4.68% up from the average. Cardinal Health, Inc. (NYSE:CAH) has declined 4.95% since January 19, 2017 and is downtrending. It has underperformed by 21.65% the S&P500.

Investors sentiment increased to 0.9 in Q3 2017. Its up 0.03, from 0.87 in 2017Q2. It improved, as 63 investors sold CAH shares while 229 reduced holdings. 64 funds opened positions while 198 raised stakes. 275.05 million shares or 0.51% more from 273.65 million shares in 2017Q2 were reported. Bessemer Gp holds 20,492 shares or 0.01% of its portfolio. Sandy Spring Bankshares owns 6,943 shares or 0.04% of their US portfolio. Liberty Mutual Asset Mgmt accumulated 13,037 shares or 0.05% of the stock. Pub Employees Retirement Sys Of Ohio holds 0.06% or 164,931 shares in its portfolio. Victory Mgmt owns 146,353 shares. Miller Invest Lp has 0.57% invested in Cardinal Health, Inc. (NYSE:CAH). Raymond James Tru Na has invested 0.1% in Cardinal Health, Inc. (NYSE:CAH). Huntington Comml Bank has invested 0.09% in Cardinal Health, Inc. (NYSE:CAH). Central Natl Bank & accumulated 785 shares or 0.01% of the stock. Telos Mngmt Inc invested in 7,235 shares or 0.19% of the stock. Benjamin F Edwards And Inc stated it has 0.04% in Cardinal Health, Inc. (NYSE:CAH). Voya Investment Mgmt Ltd holds 0.02% or 173,545 shares. Lord Abbett & Com Limited Liability Corp holds 0.25% or 1.29M shares in its portfolio. Ariel Investments Ltd Llc stated it has 0.57% of its portfolio in Cardinal Health, Inc. (NYSE:CAH). Eaton Vance invested in 0.01% or 64,264 shares.

Cullen Frost Bankers Inc, which manages about $3.05 billion US Long portfolio, decreased its stake in Exxon Mobil Corp Com (NYSE:XOM) by 10,537 shares to 868,101 shares, valued at $71.17 million in 2017Q3, according to the filing. It also reduced its holding in Capital One Financial Corp Com (NYSE:COF) by 13,249 shares in the quarter, leaving it with 221,969 shares, and cut its stake in Adobe Systems Inc Com (NASDAQ:ADBE).

Among 20 analysts covering Cardinal Health (NYSE:CAH), 4 have Buy rating, 1 Sell and 15 Hold. Therefore 20% are positive. Cardinal Health had 45 analyst reports since August 10, 2015 according to SRatingsIntel. As per Thursday, August 4, the company rating was maintained by Deutsche Bank. Credit Suisse maintained Cardinal Health, Inc. (NYSE:CAH) rating on Thursday, July 13. Credit Suisse has “Buy” rating and $8700 target. The rating was upgraded by Goldman Sachs to “Conviction Buy” on Monday, March 7. Jefferies maintained Cardinal Health, Inc. (NYSE:CAH) on Tuesday, August 29 with “Hold” rating. The stock of Cardinal Health, Inc. (NYSE:CAH) has “Market Perform” rating given on Wednesday, April 19 by William Blair. The firm has “Mkt Perform” rating given on Wednesday, December 21 by Leerink Swann. The stock of Cardinal Health, Inc. (NYSE:CAH) earned “Hold” rating by Needham on Tuesday, April 4. The stock has “Hold” rating by Jefferies on Tuesday, October 3. The firm has “Hold” rating by Leerink Swann given on Monday, April 24. Goldman Sachs downgraded it to “Neutral” rating and $83 target in Friday, September 16 report.

First Light Asset Management Llc, which manages about $154.73 million and $315.80 million US Long portfolio, upped its stake in Array Biopharma Inc (NASDAQ:ARRY) by 897,832 shares to 1.47 million shares, valued at $18.07 million in 2017Q3, according to the filing. It also increased its holding in Healthstream Inc (NASDAQ:HSTM) by 13,199 shares in the quarter, for a total of 199,243 shares, and has risen its stake in Oxford Immunotec Global Plc (NASDAQ:OXFD).

Among 3 analysts covering Immunomedics (NASDAQ:IMMU), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Immunomedics had 15 analyst reports since July 29, 2015 according to SRatingsIntel. Jefferies maintained it with “Buy” rating and $16 target in Monday, October 9 report. Jefferies downgraded the stock to “Hold” rating in Wednesday, July 29 report. The company was maintained on Wednesday, August 16 by Cowen & Co. The stock has “Buy” rating by Jefferies on Thursday, August 17. Jefferies maintained the shares of IMMU in report on Friday, June 9 with “Buy” rating. The firm has “Market Perform” rating given on Tuesday, June 21 by Wells Fargo. The rating was maintained by Cowen & Co on Monday, July 24 with “Buy”. The firm has “Market Perform” rating by Wells Fargo given on Friday, December 4. The stock of Immunomedics, Inc. (NASDAQ:IMMU) earned “Hold” rating by Jefferies on Tuesday, March 15. The stock of Immunomedics, Inc. (NASDAQ:IMMU) has “Buy” rating given on Wednesday, December 6 by Jefferies.

Since August 21, 2017, it had 0 insider purchases, and 6 selling transactions for $2.10 million activity. $369,426 worth of stock was sold by GOLDENBERG DAVID M on Monday, August 21.

Investors sentiment increased to 1.65 in 2017 Q3. Its up 0.24, from 1.41 in 2017Q2. It improved, as 16 investors sold IMMU shares while 36 reduced holdings. 38 funds opened positions while 48 raised stakes. 111.69 million shares or 33.14% more from 83.89 million shares in 2017Q2 were reported. Thompson Davis & Company Inc invested in 0.01% or 500 shares. Moreover, First Light Asset Limited Liability has 5.81% invested in Immunomedics, Inc. (NASDAQ:IMMU) for 1.31M shares. Rhenman And Prtn Asset Management holds 500,000 shares or 0.89% of its portfolio. Natl Bank Of America De reported 66,732 shares or 0% of all its holdings. Ontario – Canada-based Royal National Bank Of Canada has invested 0% in Immunomedics, Inc. (NASDAQ:IMMU). Jane Street Grp Ltd Liability Com owns 22,164 shares or 0% of their US portfolio. 683 Capital Management Llc holds 0.33% or 225,000 shares in its portfolio. Barclays Pcl owns 6,220 shares or 0% of their US portfolio. Creative Planning invested 0.12% in Immunomedics, Inc. (NASDAQ:IMMU). Morgan Stanley accumulated 439,420 shares. Northern Tru Corporation owns 1.25M shares. Citigroup has invested 0% of its portfolio in Immunomedics, Inc. (NASDAQ:IMMU). Citadel Llc has 0.01% invested in Immunomedics, Inc. (NASDAQ:IMMU). Alliancebernstein Lp has 155,798 shares for 0% of their portfolio. Ra Capital Management Limited Co holds 1.87% in Immunomedics, Inc. (NASDAQ:IMMU) or 1.48M shares.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>